(Q37589149)

21 August 2017

1 reference

title

Screening for and early detection of chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

21 August 2017

main subject

0 references

Joan B Soriano

1

0 references

David Price

object named as

David Price

series ordinal

3

0 references

author name string

Jan Zielinski

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

374

1 reference

21 August 2017

issue

9691

1 reference

21 August 2017

page(s)

721-732

1 reference

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Chronic obstructive pulmonary disease: current burden and future projections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Global Burden of Disease 2005: call for collaborators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Global burden of COPD: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Prevalence, severity and underdiagnosis of COPD in the primary care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Biomedical risk assessment as an aid for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Trends in the leading causes of death in the United States, 1970-2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

COPD screening efforts in primary care: what is the yield?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Primary care spirometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

[Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

NICE guidance for COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Sick individuals and sick populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Occupational exposures and COPD: an ecological analysis of international data.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Estimates of global and regional potential health gains from reducing multiple major risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Smoked marijuana as a cause of lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Effects of cannabis on pulmonary structure, function and symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Biomass fuels and respiratory diseases: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

The nature of small-airway obstruction in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

A modern concept of the emphysemas based on correlations of structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Decline in FEV1in Relation to Incident Chronic Obstructive Pulmonary Disease in a Cohort with Respiratory Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Smoking and lung function of Lung Health Study participants after 11 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Natural histories of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Spirometry in primary care case-identification, diagnosis and management of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Early detection of COPD in a high-risk population using spirometric screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Increasing COPD awareness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Asthma Programme in Finland: the quality of primary care spirometry is good

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Pulmonary Function: Relation to Aging, Cigarette Habit, and Mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Global strategy for asthma management and prevention: GINA executive summary.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Reversing concepts on COPD irreversibility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Spirometric reference values from a sample of the general U.S. population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Reference ranges for spirometry across all ages: a new approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Cross-sectional and longitudinal spirometry in children and adolescents: interpretative strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Interpretation of pulmonary function test: issues and controversies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Physician advice for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

The natural history of chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Should general practitioners screen smokers for COPD?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Standardisation of spirometry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Geographic variation of spirometry use in newly diagnosed COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Attaining a correct diagnosis of COPD in general practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Effect of primary-care spirometry on the diagnosis and management of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Impact of chronic airflow obstruction in a working population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

The health impact of undiagnosed airflow obstruction in a national sample of United States adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Mortality in relation to smoking: 50 years' observations on male British doctors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961290-3

7 January 2021

10.1016/S0140-6736(09)61290-3

Identifiers

DOI

1 reference

21 August 2017

1 reference